|
01.08.12
|
|
Vertex Pharmaceuticals outperform
|
Credit Suisse Group
|
|
31.07.12
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
31.07.12
|
|
Vertex Pharmaceuticals buy
|
UBS AG
|
|
27.07.12
|
|
Vertex Pharmaceuticals kaufen
|
Fuchsbriefe
|
|
02.07.12
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
12.06.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
28.05.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
09.05.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
|
|
08.05.12
|
|
Vertex Pharmaceuticals buy
|
Needham & Company, LLC
|
|
30.04.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
12.04.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
28.03.12
|
|
Vertex Pharmaceuticals neutral
|
UBS AG
|
|
06.02.12
|
|
Vertex Pharmaceuticals neutral
|
Goldman Sachs Group Inc.
|
|
02.02.12
|
|
Vertex Pharmaceuticals overweight
|
Barclays Capital
|
|
16.12.11
|
|
Vertex Pharmaceuticals outperform
|
Credit Suisse Group
|
|
05.12.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
22.11.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
11.11.11
|
|
Vertex Pharmaceuticals neutral
|
UBS AG
|
|
08.11.11
|
|
Vertex Pharmaceuticals neutral
|
Robert W. Baird & Co. Incorporated
|
|
07.11.11
|
|
Vertex Pharmaceuticals sector perform
|
RBC Capital Markets
|
|
03.11.11
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
13.10.11
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
11.10.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
06.10.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
05.10.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
04.10.11
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
07.09.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
30.08.11
|
|
Vertex Pharmaceuticals buy
|
Citigroup Corp.
|
|
18.08.11
|
|
Vertex Pharmaceuticals outperform
|
William Blair
|
|
04.04.11
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
25.02.11
|
|
Vertex Pharmaceuticals hold
|
ThinkEquity Partners LLC
|
|
24.02.11
|
|
Vertex Pharmaceuticals hold
|
ThinkEquity Partners LLC
|
|
24.02.11
|
|
Vertex Pharmaceuticals overweight
|
Piper Jaffray & Co.
|
|
24.02.11
|
|
Vertex Pharmaceuticals buy
|
Goldman Sachs Group Inc.
|
|
08.02.11
|
|
Vertex Pharmaceuticals buy
|
Goldman Sachs Group Inc.
|
|
22.12.10
|
|
Vertex Pharmaceuticals outperform
|
RBC Capital Markets
|
|
30.07.10
|
|
Vertex Pharmaceuticals neutral
|
Wedbush Morgan Securities Inc.
|
|
27.05.10
|
|
Vertex Pharmaceuticals kaufen
|
Needham & Company, LLC
|
|
26.05.10
|
|
Vertex Pharmaceuticals halten
|
Wedbush Morgan Securities Inc.
|
|
23.04.10
|
|
Vertex Pharmaceuticals kaufen
|
Needham & Company, LLC
|
|
13.04.10
|
|
Vertex Pharmaceuticals halten
|
JP Morgan Chase & Co.
|
|
05.02.10
|
|
Vertex Pharmaceuticals kaufen
|
Morgan Stanley
|
|
04.12.09
|
|
Vertex Pharmaceuticals outperform
|
Leerink Swann LLC
|
|
03.12.09
|
|
Vertex Pharmaceuticals neutral
|
Wedbush Morgan Securities Inc.
|
|
17.11.09
|
|
Vertex Pharmaceuticals neutral
|
Merriman Curhan Ford & Co
|
|
05.11.09
|
|
Vertex Pharmaceuticals overweight
|
Morgan Stanley
|
|
03.11.09
|
|
Vertex Pharmaceuticals neutral
|
Goldman Sachs Group Inc.
|
|
05.05.09
|
|
Vertex Pharmaceuticals
|
Global Biotech Investing
|
|
04.03.09
|
|
Vertex Pharmaceuticals outperform
|
Credit Suisse Group
|
|
10.02.09
|
|
Vertex Pharmaceuticals outperform
|
Credit Suisse Group
|
